biOasis Technologies Ord Shs V.BTI.H

Primary Symbol: BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

GREY:BIOAF - Post by User

biOasis Technologies Ord Shs > Is Chiesi a big surprise for 2023?

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Dec 27, 2022 2:37pm

109 Views

Post# 35192665

RE:RE:Is Chiesi a big surprise for 2023?

POOF says, Another factor, in Midatech's presentation Midatech's CEO stressed the importance of BTI's partnerships as part of the deal. He likely has more information about Chiesi to support the merger.

Jeepers, why hasn't anyone thought of that???????????

Let me check!!! MTP should be soaring on that revelation!!!!!!!!

Oh, wait, it's still at 0.77 and an untradeable spread of 0.74 x 0.815.

Never mind.

I asked "how many different ways you can continue to restate your last 100 posts?"

Hey brother man, good thinking. No need to restate them, just repost them.

<< Previous

Bullboard Posts

Next >>

Transportation technology stock secures second major contract in a week